With few remaining unapproved drugs, researchers tell FDA its Unapproved Drugs Initiative is no longer effective
Back in May, the FDA decided to reverse a Trump-era decision to pull the agency’s controversial Unapproved Drugs Initiative, with the FDA citing multiple …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
